Target intelligence / Profile preview

Specificity protein 1-DNA complex (Sp1-DNA complex)

Target
Sp1-DNA complex
Molecular classification
Transcription factor, DNA-protein complex, Zinc finger protein
01

Overview

The Specificity protein 1 (Sp1)-DNA complex is a critical regulatory assembly formed when the Sp1 transcription factor binds to GC-rich motifs, known as GC boxes, within the promoter regions of numerous genes [1]. Sp1 utilizes its three C-terminal Cys2His2-type zinc finger domains to recognize and bind these sequences, facilitating the recruitment of the basal transcription machinery and other co-activators to initiate gene expression [1, 3]. This complex plays a pivotal role in regulating essential cellular processes, including the cell cycle, apoptosis, and angiogenesis [3]. In many pathological states, particularly in various cancers and viral infections like HIV-1, Sp1 is often overexpressed or hyperactive, driving the transcription of oncogenes and viral proteins [2, 3]. Consequently, the Sp1-DNA complex has emerged as a therapeutic target, with drugs like Mithramycin A acting as DNA-binding agents that displace Sp1 from its cognate sites [2, 4]. However, because Sp1 regulates a vast array of housekeeping genes, targeting this complex presents significant challenges regarding systemic toxicity and off-target effects [3, 4]. (Sources: [1] UniProt P08047; [2] PMID: 11509595; [3] PMID: 24013078; [4] PMID: 17189388)

Other names
Sp1-GC box complexTranscription factor Sp1-DNA complexSpecificity protein 1-promoter complexSp1-DNA binding site
02

Mechanism of action

Competitive inhibition of transcription factor binding to DNA by small molecules that occupy the GC-rich minor groove or modify the DNA structure, thereby preventing the recruitment of the transcriptional machinery.

03

Biological functions

Gene expression regulationCell cycle regulationApoptosisCell differentiationAngiogenesisChromatin remodeling
04

Disease associations

CancerViral infection (e.g., HIV-1)InflammationHuntington's diseaseCardiovascular disease
05

Safety considerations

Systemic toxicity (e.g., hepatotoxicity and nephrotoxicity)Non-specific inhibition of essential housekeeping genesNarrow therapeutic indexPotential for widespread transcriptional dysregulation
06

Interacting drugs

Mithramycin A (Plicamycin)

4 more in the full profile.

07

Biomarkers

Sp1 protein expression levelsGC-box occupancyVEGF expression levelsc-Myc expression levelsSp1 phosphorylation status

Beyond the preview

Go deeper on Specificity protein 1-DNA complex (Sp1-DNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Specificity protein 1-DNA complex (Sp1-DNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call